Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures

Phase 4RecruitingNCT05076110

Mayo Clinic188 enrolled

Overview

This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

188

Conditions

Hip Arthroscopy

Interventions

OxycodoneDRUG

5 mg tablets every 4 hours postoperatively as needed for pain control

IbuprofenDRUG

800 mg three times a day for 2 weeks postoperatively for pain control; not to exceed 3200 mg/day

GabapentinDRUG

300 mg three times a day for 5 days then wean off by day 10 postoperatively

Eligibility

Sex: ALLMin age: 16 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: • Scheduled for a primary Hip Arthroscopy at Mayo Clinic (Rochester, MN) Exclusion Criteria: * medical history of known allergies or intolerance to allergies or intolerance to Motrin, Gabapentin, Tylenol, dexamethasone, tramadol, or Robaxin. * Substantial alcohol or drug abuse. * History of narcotics within 6 months of surgery. * Pregnancy. * Renal impairment. * Peptic ulcer disease. * GI bleeding.

Locations (1)

Mayo clinic

Rochester, Minnesota, United States

RECRUITING

Outcomes

Primary Outcomes

Change in pain score

Measure using a visual analog scale (VAS) to rate pain on a scale 0-10; 0=no pain to 10=worst possible pain

Time frame: Baseline, 14 days post-operatively

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.